falsefalse

The Evolving Treatment Landscape in Light Chain Amyloidosis with Cardiac Involvement - Episode 9

Revolutionizing the AL Amyloidosis Treatment Paradigm: Novel Agents and Combination Approaches

,

Expert oncologists discuss the progression treatment landscape in AL amyloidosis and agents of investigation.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: AL Amyloidosis: Background, Patient Profile, and Staging
    EP. 2: Navigating the Differential Diagnosis of AL Amyloidosis
    EP. 3: Treatment Approaches in AL Amyloidosis
    EP. 4: Limitations of Available Treatment Options for Patients with Cardiac Involvement
    EP. 5: Birtamimab in AL Amyloidosis: Key Takeaways from the Phase III VITAL Trial
    EP. 6: Birtamimab Safety Profile in the VITAL Study
    EP. 7: Adverse Event Management in AL Amyloidosis
    EP. 8: Ongoing AFFIRM-AL Trial Background, Patient Eligibility, and Active Enrollment
    Now Viewing
    EP. 9: Revolutionizing the AL Amyloidosis Treatment Paradigm: Novel Agents and Combination Approaches
    EP. 10: Clinical Pearls and Future Directions in AL Amyloidosis

    Related Content:

    The Evolving Treatment Landscape in Light Chain Amyloidosis with Cardiac InvolvementInsightsInsights Video Series
    Presenting the Treatment Options in EGFR-Mutant NSCLC: Weighing the Data and Incorporating the Patient Perspective
    Treatment Planning for HER2+ Breast Cancer: The Role of Ovarian Function Suppression
    Practical Recommendations for Community Oncologists
    x